ZEAL:CPH
Zealand Pharma A/S
229,10 DKK
arrow_downward
-0,95%(-2,20) 1D
14 tet, 1:24:02 m.d., GMT+2 · DKK
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ZEAL...
Hap
232,00 DKK
I lartë
234,60 DKK
I ulët
227,40 DKK
Kapitalizimi i tregut
16,81 mld
Vëllimi mesatar
402,85 mijë
Vëllimi
145,31 mijë
Maksimumi 52-javor
556,00 DKK
Minimumi 52-javor
227,40 DKK
Aksionet në qarkullim
71,61 mln
Numri i punonjësve
578
Hap
232,00 DKK
I lartë
234,60 DKK
I ulët
227,40 DKK
Kapitalizimi i tregut
16,81 mld
Vëllimi mesatar
402,85 mijë
Vëllimi
145,31 mijë
Maksimumi 52-javor
556,00 DKK
Minimumi 52-javor
227,40 DKK
Aksionet në qarkullim
71,61 mln
Numri i punonjësve
578
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Euronext Markets: Real-time Stock Market Data | live
·
14 orë më parë
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Investing.com Canada
·
14 orë më parë
Zealand Pharma partners with Generate on AI drug development By Investing.com
Investing.com Canada
·
14 orë më parë
Generate Biomedicines, Zealand Pharma form AI drug partnership By Investing.com
Stock Titan
·
14 orë më parë
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profili
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Rreth Zealand Pharma A/S
Drejtori ekzekutivAdam Steensberg
Punonjësit578
Themeluar më1 pri 1997
Selia-
Sektori-
Uebsajtizealandpharma.com